| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Australia | 1 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Israel | 1 | |
| #7 | Singapore | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Knappe Thomas | 8 |
| #2 | Bisek Nicola | 8 |
| #3 | Laufer Burkhardt | 6 |
| #4 | Rau Harald | 5 |
| #5 | Tabrizifard Mohammad A | 4 |
| #6 | Punnonen Juha | 4 |
| #7 | Sprogøe Kennett | 4 |
| #8 | Zuniga Luis | 2 |
| #9 | Rosen David B | 2 |
| #10 | Kennett Sprogøe | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020254617A1 | Anti-ctla4 compounds with localized pk properties | |
| WO2020254609A1 | Tyrosine kinase inhibitor conjugates | |
| WO2020254607A1 | Anti-ctla4 compounds with localized pd properties | |
| WO2020254613A1 | Controlled-release tyrosine kinase inhibitor compounds with localized pk properties | |
| WO2020254611A1 | Anti-ctla4 conjugates | |
| WO2020254612A1 | Controlled-release tyrosine kinase inhibitor compounds with localized pd properties | |
| AU2019246389A1 | IL-2 conjugates |